Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
50419
Strengths
Gadoquatrane 257.9 mg/mL; Gadobutrol 604.72 mg/mL; Sorafenib 200 mg/1; Larotrectinib 20 mg/mL; Iopromide 300 mg/mL; Iopromide 370 mg/mL; Sevabertinib 10 mg/1; Elinzanetant 60 mg/1; Finerenone 10 mg/1; Finerenone 20 mg/1; Finerenone 40 mg/1; Nifurtimox 30 mg/1; Nifurtimox 120 mg/1; Darolutamide 300 mg/1; Larotrectinib 25 mg/1; Larotrectinib 100 mg/1; Levonorgestrel 19.5 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1
Dosage forms
Injection, Tablet, Film coated, Kit, Patch, Capsule, Intrauterine device, Solution, Concentrate, Tablet, Injection, Solution
Routes
Oral, Intravenous, Transdermal, Intra-arterial, Intrauterine, Oropharyngeal
Drug classes (FDA established)
Estrogen, Kinase Inhibitor, Progestin, Soluble Guanylate Cyclase Stimulator, Radiographic Contrast Agent, Progestin-containing Intrauterine System, Gadolinium-based Contrast Agent, Nonsteroidal Mineralocorticoid-Receptor Antagonist, Fluoroquinolone Antibacterial, Radioactive alpha-Particle Emitting Therapeutic Agent, Anthelmintic
HCPCS / J-code
None in Med-Code's directory for these products
Package NDCs
148

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Bayer HealthCare Pharmaceuticals Inc. NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-32150419-0321-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-32250419-0322-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-32350419-0323-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-32450419-0324-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-32650419-0326-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-32750419-0327-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-32850419-0328-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-32950419-0329-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-33050419-0330-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-33150419-0331-11—
AmbelvistgadoquatraneGadoquatrane 257.9 mg/mLInjectionIntravenous50419-33250419-0332-11—
HyrnuosevabertinibSevabertinib 10 mg/1Tablet, Film coatedOral50419-39750419-0397-01—
LynkuetelinzanetantElinzanetant 60 mg/1CapsuleOral50419-47550419-0475-0550419-0475-7250419-0475-73—
NexavarsorafenibSorafenib 200 mg/1Tablet, Film coatedOral50419-48950419-0489-01—
VitrakvilarotrectinibLarotrectinib 20 mg/mLSolution, ConcentrateOropharyngeal50419-39350419-0393-03—
UltravistiopromideIopromide 300 mg/mLInjectionIntra-arterial, Intravenous50419-34750419-0347-0550419-0347-20—
UltravistiopromideIopromide 370 mg/mLInjectionIntra-arterial, Intravenous50419-34850419-0348-0550419-0348-1050419-0348-11+4 more—
KerendiafinerenoneFinerenone 10 mg/1Tablet, Film coatedOral50419-54050419-0540-0150419-0540-0250419-0540-06+1 more—
KerendiafinerenoneFinerenone 20 mg/1Tablet, Film coatedOral50419-54150419-0541-0150419-0541-0250419-0541-06+1 more—
KerendiafinerenoneFinerenone 40 mg/1TabletOral50419-54250419-0542-0150419-0542-0250419-0542-06+1 more—
LampitnifurtimoxNifurtimox 30 mg/1Tablet, Film coatedOral50419-75050419-0750-01—
LampitnifurtimoxNifurtimox 120 mg/1Tablet, Film coatedOral50419-75150419-0751-01—
NubeqadarolutamideDarolutamide 300 mg/1Tablet, Film coatedOral50419-39550419-0395-0150419-0395-72—
VitrakvilarotrectinibLarotrectinib 25 mg/1CapsuleOral50419-39050419-0390-01—
VitrakvilarotrectinibLarotrectinib 100 mg/1CapsuleOral50419-39150419-0391-01—
VitrakvilarotrectinibLarotrectinib 20 mg/mLSolution, ConcentrateOropharyngeal50419-39250419-0392-01—
KyleenalevonorgestrelLevonorgestrel 19.5 mg/1Intrauterine deviceIntrauterine50419-42450419-0424-0150419-0424-0850419-0424-71—
AdempasriociguatRiociguat .5 mg/1Tablet, Film coatedOral50419-25050419-0250-0150419-0250-0350419-0250-71+1 more—
AdempasriociguatRiociguat 1 mg/1Tablet, Film coatedOral50419-25150419-0251-0150419-0251-0350419-0251-71+1 more—
AdempasriociguatRiociguat 1.5 mg/1Tablet, Film coatedOral50419-25250419-0252-0150419-0252-0350419-0252-91—
AdempasriociguatRiociguat 2 mg/1Tablet, Film coatedOral50419-25350419-0253-0150419-0253-0350419-0253-91—
AdempasriociguatRiociguat 2.5 mg/1Tablet, Film coatedOral50419-25450419-0254-0150419-0254-0350419-0254-91—
Xofigoradium ra 223 dichlorideRadium ra-223 dichloride 30 uCi/mLInjectionIntravenous50419-20850419-0208-01—
SkylalevonorgestrelLevonorgestrel 13.5 mg/1Intrauterine deviceIntrauterine50419-42250419-0422-0150419-0422-08—
StivargaregorafenibRegorafenib 40 mg/1Tablet, Film coatedOral50419-17150419-0171-0050419-0171-0350419-0171-04+1 more—
Angeliqdrospirenone and estradiolEstradiol .5 mg/1; Drospirenone .25 mg/1Tablet, Film coatedOral50419-48250419-0482-0350419-0482-72—
Safyraldrospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium—Kit50419-40350419-0403-0050419-0403-0350419-0403-70+1 more—
BiltricidepraziquantelPraziquantel 600 mg/1Tablet, Film coatedOral50419-74750419-0747-01—
GadavistgadobutrolGadobutrol 604.72 mg/mLInjectionIntravenous50419-32550419-0325-1150419-0325-1250419-0325-13+6 more—
GadavistgadobutrolGadobutrol 604.72 mg/mLInjectionIntravenous50419-32550419-0325-1850419-0325-1950419-0325-73+1 more—
GadavistgadobutrolGadobutrol 604.72 mg/mLInjectionIntravenous50419-325——
Beyazdrospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium—Kit50419-40750419-0407-0050419-0407-0350419-0407-70+1 more—
Nataziaestradiol valerate and estradiol valerate/dienogest—Kit50419-40950419-0409-0050419-0409-0350419-0409-73+1 more—
UltravistiopromideIopromide 300 mg/mLInjectionIntra-arterial, Intravenous50419-34450419-0344-0550419-0344-1050419-0344-12+8 more—
UltravistiopromideIopromide 370 mg/mLInjectionIntra-arterial, Intravenous50419-34650419-0346-0550419-0346-1050419-0346-15+7 more—
MirenalevonorgestrelLevonorgestrel 52 mg/1Intrauterine deviceIntrauterine50419-42350419-0423-0150419-0423-08—
Betaseroninterferon beta-1b—Kit50419-52450419-0524-0550419-0524-0950419-0524-35+1 more—
Eovistgadoxetate disodiumGadoxetate disodium 181.43 mg/mLInjection, SolutionIntravenous50419-32050419-0320-0550419-0320-1550419-0320-75—
ClimaraestradiolEstradiol .06 mg/dPatchTransdermal50419-45950419-0459-04—
Yazdrospirenone and ethinyl estradiol—Kit50419-40550419-0405-03—

Bayer HealthCare Pharmaceuticals Inc.: common questions

What is Bayer HealthCare Pharmaceuticals Inc.'s NDC labeler code?
50419. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for Bayer HealthCare Pharmaceuticals Inc.?
Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in